Quick Answer
Monopar Therapeutics reported Total Revenue of $0.00 for fiscal year 2019.
Monopar Therapeutics Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2019 | $0.00 | — |
| 2018 | $0.00 | — |
| 2017 | $0.00 | — |
| 2016 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2019 | $0.00 | — | — |
| June 30, 2019 | $0.00 | — | — |
| March 31, 2019 | $0.00 | — | — |
| September 30, 2018 | $0.00 | — | — |
| June 30, 2018 | $0.00 | — | — |
| March 31, 2018 | $0.00 | — | — |
| September 30, 2017 | $0.00 | — | — |
| June 30, 2017 | $0.00 | — | — |
- The most recent figure is from Monopar Therapeutics’s fiscal year 2019 report (Form 10-K), filed with the SEC on March 27, 2020.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: